Cargando…

Composite neurocognitive endpoints in Alzheimer's disease clinical trials: A commentary

Detalles Bibliográficos
Autor principal:	Randolph, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819350/ https://www.ncbi.nlm.nih.gov/pubmed/33521232 http://dx.doi.org/10.1002/dad2.12010

Ejemplares similares

Imaging endpoints for clinical trials in Alzheimer’s disease
por: Cash, David M, et al.
Publicado: (2014)

Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer’s Disease
por: Cohen, S., et al.
Publicado: (2022)

Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease
por: Insel, Philip S, et al.
Publicado: (2015)

Understanding the Use of Composite Endpoints in Clinical Trials
por: McCoy, C. Eric
Publicado: (2018)

Planning and analyzing clinical trials with composite endpoints
por: Rauch, Geraldine, et al.
Publicado: (2017)

Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials
por: Vaanholt, Melissa C.W., et al.
Publicado: (2018)

Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities
por: Brem, Anna-Katharine, et al.
Publicado: (2023)

Improving the analysis of composite endpoints in rare disease trials
por: McMenamin, Martina, et al.
Publicado: (2018)

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
por: Rabe, Klaus F., et al.
Publicado: (2020)

Analysis of neurocognitive function and CNS endpoints in the PROTEA trial: darunavir/ritonavir with or without nucleoside analogues
por: Clarke, Amanda, et al.
Publicado: (2014)

Commentary on: A call for better reporting of trials using surrogate primary endpoints
por: Cummings, Jeffrey
Publicado: (2022)

Commentary on Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Rentz, Dorene M., et al.
Publicado: (2020)

Commentary: Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Harrison, John E.
Publicado: (2020)

Proof of concept demonstration of optimal composite MRI endpoints for clinical trials
por: Edland, Steven D., et al.
Publicado: (2016)

Commentary: Visual attention is not deployed at the endpoint of averaging saccades
por: Van der Stigchel, Stefan, et al.
Publicado: (2018)

Making Sense of Composite Endpoints in Clinical Research
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2023)

Impact of non‐binding FDA guidances on primary endpoint selection in Alzheimer's disease trials
por: Yu, Jeffrey C., et al.
Publicado: (2022)

Exploring Neurocognitive Deterioration in Alzheimer’s Disease
por: Franzoni, Ferdinando, et al.
Publicado: (2023)

IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)

The Importance of Endpoints in Oncology Clinical Trials
por: Faiman, Beth
Publicado: (2023)

Response to peer commentaries: Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Schneider, Lon S., et al.
Publicado: (2020)

Vitamin D and Alzheimer's Disease: Neurocognition to Therapeutics
por: Banerjee, Anindita, et al.
Publicado: (2015)

Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
por: Kristensen, Anna Meta Dyrvig, et al.
Publicado: (2022)

The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
por: Wang, Duolao, et al.
Publicado: (2011)

Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Importance of achieving the composite endpoints in diabetes
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2013)

Efficacy Endpoints in Clinical Trials in Actinic Keratosis
por: Skov, Torsten, et al.
Publicado: (2018)

Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities
por: Roy-Chaudhury, Prabir
Publicado: (2017)

Patients’ preferences for selection of endpoints in cardiovascular clinical trials
por: Chow, Robert D., et al.
Publicado: (2014)

Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia
por: Naito, Tateaki
Publicado: (2019)

Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
por: McDonald, James, et al.
Publicado: (2023)

The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials
por: Thorlund, Kristian, et al.
Publicado: (2023)

Composite endpoints, including patient reported outcomes, in rare diseases
por: Verbeeck, Johan, et al.
Publicado: (2023)

A potential primary endpoint for clinical trials in glaucoma neuroprotection
por: De Moraes, Carlos Gustavo, et al.
Publicado: (2023)

Misspecification of Cox regression models with composite endpoints
por: Wu, Longyang, et al.
Publicado: (2012)

Is more involvement needed in the clinical trial design & endpoints?
por: Vroom, Elizabeth
Publicado: (2012)

Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
por: Hilbrands, Luuk, et al.
Publicado: (2022)

Sample size determination in clinical trials with multiple endpoints
por: Sozu, Takashi, et al.
Publicado: (2015)

The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer’s disease treatment?
por: Evans, Stephanie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4sbpsucictfpv8g2jbmfscvgl3